Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Georgetown University Identifier:
First received: July 11, 2001
Last updated: March 23, 2011
Last verified: January 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2004
  Primary Completion Date: October 2004 (Final data collection date for primary outcome measure)